These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10913488)

  • 21. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes.
    Wägner AM; Ordóñez-Llanos J; Jorba O; Pérez A
    Metabolism; 2004 Nov; 53(11):1516. PubMed ID: 15558848
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemia.
    Farnier M; Portal JJ; Maigret P
    J Cardiovasc Pharmacol Ther; 2000 Jan; 5(1):27-32. PubMed ID: 10687671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
    Goldberg RB; Guyton JR; Mazzone T; Weinstock RS; Polis A; Edwards P; Tomassini JE; Tershakovec AM
    Mayo Clin Proc; 2006 Dec; 81(12):1579-88. PubMed ID: 17165637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia.
    Dart A; Jerums G; Nicholson G; d'Emden M; Hamilton-Craig I; Tallis G; Best J; West M; Sullivan D; Bracs P; Black D
    Am J Cardiol; 1997 Jul; 80(1):39-44. PubMed ID: 9205017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia.
    Frost RJ; Otto C; Geiss HC; Schwandt P; Parhofer KG
    Am J Cardiol; 2001 Jan; 87(1):44-8. PubMed ID: 11137832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atorvastatin versus simvastatin.
    Calder RA
    Am J Cardiol; 1997 Dec; 80(12):1646. PubMed ID: 9416964
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.
    Davidson M; Ma P; Stein EA; Gotto AM; Raza A; Chitra R; Hutchinson H
    Am J Cardiol; 2002 Feb; 89(3):268-75. PubMed ID: 11809427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin effects on LDL and HDL cholesterol in South Asian and white populations.
    Gupta M; Braga MF; Teoh H; Tsigoulis M; Verma S
    J Clin Pharmacol; 2009 Jul; 49(7):831-7. PubMed ID: 19398601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
    Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
    J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LDL cholesterol variability in patients with Type 2 diabetes taking atorvastatin and simvastatin: a comparison of two formulae for LDL-C estimation.
    Sathyapalan T; Atkin SL; Kilpatrick ES
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):180-2. PubMed ID: 24719214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of elastic properties of magistral arteries in patients with ischemic heart disease during treatment with atorvastatin and simvastatin].
    Iliukhin OV; Kalganova EL; Babkin AA; Lopatin IuM
    Kardiologiia; 2005; 45(12):31-4. PubMed ID: 16353044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative economic analysis of simvastatin versus atorvastatin: results of the Surrogate Marker Cost-Efficacy (SMaC) study.
    Arikian S
    Clin Ther; 2000 Apr; 22(4):494-6. PubMed ID: 10823368
    [No Abstract]   [Full Text] [Related]  

  • 37. Construction of atorvastatin dose-response relationships using data from a large population-based DNA biobank.
    Peissig P; Sirohi E; Berg RL; Brown-Switzer C; Ghebranious N; McCarty CA; Wilke RA
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):286-8. PubMed ID: 17371534
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the effects of atorvastatin versus simvastatin on subclinical atherosclerosis in primary preventionas determined by electronbeam tomography.
    Hecht HS; Harman SM
    Am J Cardiol; 2003 Jan; 91(1):42-5. PubMed ID: 12505569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemia.
    Milionis HJ; Bairaktari ET; Liberopoulos EN; Elisaf MS
    Am J Cardiol; 2001 Jul; 88(2):203. PubMed ID: 11463061
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.
    Smilde TJ; van Wissen S; Wollersheim H; Trip MD; Kastelein JJ; Stalenhoef AF
    Lancet; 2001 Feb; 357(9256):577-81. PubMed ID: 11558482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.